Australian biotech Starpharma has signed a memorandum of understanding with a Chinese company to make and sell its VivaGel-coated condom in China.
VivaGel has both antibacterial and antiviral properties and has been shown in laboratory studies to inactivate common viruses that cause sexually-transmitted infections.
The Chinese company is a major supplier of condoms to the Chinese government's Birth Control Department and Disease Prevention Department.
The so-called government market in China requires about three billion condoms each year for birth control and disease prevention.
